So far, Eli Lilly has only released the two lowest doses of Zepbound in vials, but at a significant savings for people without good insurance coverage. The medicine will still be expensive ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Fact checked by Nick BlackmerFact checked by Nick Blackmer Zepbound, a popular weight management drug, will now be sold in vials in addition to preloaded injector pens. Patients will have to draw ...

This form of Zepbound is sold as a vial that needs to be given by a syringe, although patients can still do it themselves. Zepbound and Mounjaro are both brand names for tirzepatide. However ...

Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.

Eli Lilly officials announced a new program that provides consumers with single-dose vials of the weight-loss drug Zepbound at a discount price of 50% or more. Consumers who pay for these ...

Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity Lilly has created a new ...

There is no way of prescribing a higher dose of Zepbound vials, so patients would have to resort to the higher-dose auto-injector pens that are still double the price." A Lilly spokesperson ...

Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity INDIANAPOLIS, Aug. 27, ...